Sera Prognostics, Inc. (SERA) stock
SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
$1.98+0.04 (+2.06%)
Close on Nov 12, 2026Market cap $78.11MP/E –Yield –
Sera Prognostics gross margin
Gross margin is gross profit as a percentage of revenue.
Sera Prognostics's gross margin for the twelve months ending Jun 30, 2026 was -150.0%. For fiscal 2025 it was -102.5%, against -6.5% the year before.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -102.5% | −96.0 |
| FY2024 | Dec 31, 2024 | -6.5% | −37.9 |
| FY2023 | Dec 31, 2023 | 31.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -66.7% | +74.5 |
| Q1 FY2026 | Mar 31, 2026 | -200.0% | −194.7 |
| Q4 FY2025 | Dec 31, 2025 | -320.0% | −286.7 |
| Q3 FY2025 | Sep 30, 2025 | -156.3% | −211.4 |
| Q2 FY2025 | Jun 30, 2025 | -141.2% | −157.8 |
| Q1 FY2025 | Mar 31, 2025 | -5.3% | – |
| Q4 FY2024 | Dec 31, 2024 | -33.3% | – |
| Q3 FY2024 | Sep 30, 2024 | 55.2% | – |
| Q2 FY2024 | Jun 30, 2024 | 16.7% | – |
See a number that looks wrong?